Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3569-3576

  Li, Jian Jian ^a   Westergaard, Chandra ^a   Ghosh, Paritosh ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHLORAMPHENICOL ACETYLTRANSFERASE; COLLAGENASE; DITHIOCARBAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; RETINOID; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROMOTER;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR PROMOTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA; GENES, REPORTER; MICE; NF-KAPPA B; PYRROLIDINES; RETINOIDS; TETRADECANOYLPHORBOL ACETATE; THIOCARBAMATES; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030800330     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Colburn, N. H., Former, B. F., Nelson, K. A., and Yuspa, S. H. Tumour promoter induces anchorage independence irreversibly. Nature (Lond.), 281: 589-591, 1979.
2. Colburn, N. H., Wendel, E., and Srinivas, L. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies. J. Cell. Biochem., 18: 261-270, 1982.
3. Bernstein, L. R., Bravo, R., and Colburn, N. H. 12-O-Tetradecanoylphorbol-13-acetate-induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells. Mol. Carcinog., 6: 221-229, 1992.
4. Bernstein, L. R., and Colburn, N. H. AP1/Jun function is differentially induced in promotion sensitive and resistant JB6 cells. Science (Washington DC), 244: 566-569, 1989.
5. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA, 91: 609-613, 1994.
6. Brown, P. H., Chen, T. K., and Birrer, M. J. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene, 9: 791-799, 1994.
7. Dong, Z., Crawford, H. C., Lavrovsky, V., Taub, D., Watts, R., Ma, W-Y., Matrisian, L. M., and Colburn, N. H. A dominant negative mutant of Jun blocks TPA-induced invasion: involvement of matrix metalloproteinase gene expression. Mol. Carcinog, 19: 204-212, 1997.
8. Li, J-J., Vousden, M. H., Schlegel, R., and Colburn, N. H. AP-1 and NF-κB transactivation in E6/E7 immortalized human keratinocytes. Proc. Am. Assoc. Cancer Res., 37: 531, 1996.
9. Angel, A., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
10. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell, 49: 729-739, 1987.
11. Lee, W., Haslinger, A., Karin, M., and Tjian, B. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (Lond.), 325: 368-372, 1987.
12. Nolan, G. P., and Baltimore, D. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev., 2: 211-220, 1992.
13. Baeuerle, P. A., and Baltimore, D. NF-κB. Ten years after. Cell, 87: 13-20, 1996.
14. Baeuerle, P. A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem. Biophys. Aeta, 1072: 63-80, 1991.
15. Baeuerle, P. A., and Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12: 141-179, 1994.
16. Rice, N. R., MacKichan, M. L., and Israel, A. The precursor of NF-κ B p50 has I κ B-like functions. Cell, 71: 243-253, 1992.
17. Sun, S-C., Ganchi, P. A., Ballard, D. W., and Greene, W. C. NF-κ B controls expression of inhibitor I κ B α: evidence for an inducible autoregulatory pathway. Science (Washington DC), 259: 1912-1915, 1993.
18. Sun, S-C., Ganchi, P. A., Beraud, C., Ballard, D. W., and Greene, W. C. Autoregulation of the NF-κ B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA, 91: 1346-1350, 1994.
19. Beauparlant, P., Kwan, I., Bitar, R., Chou, P., Koromilas, A. E., Sonenberg, N., and Hiscott, J. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene, 9: 3189-3197, 1994.
20. Stein, B., Baldwin, A. S., Jr., Ballard, D. W., Greene, W. C., Angel, P., and Herrlich, P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12: 3879-3891, 1993.
21. Colburn, N. H., Ozanne, S., Lichti, U., Ben, T., Yuspa, S. H., Wendel, E., Jardini, E., and Abruzzo, G. Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines. Ann. NY Acad. Sci., 359: 251-259, 1981.
22. Verma, A. K., and Boutwell, R. K. Vitamin A acid (retinoic acid), a potent inhibitor or 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidemis. Cancer Res., 37: 2196-2201, 1977.
23. Li, J-J., Dong, Z., Dawson, M. I., and Colburn, N. H. Inhibition of tumor promoter induced transformation by retinoids that transrepress AP-1 without transactivating RARE. Cancer Res., 56: 483-489, 1996.
24. Jetten, A. M., and Goldfarb, R. H. Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells. Cancer Res., 43: 2094-2099, 1983.
25. Bollag, W., and Holdener, E. E. Retinoids in cancer prevention and therapy. Ann. Oncol., 3: 513-526, 1992.
26. Soprano, D. R., Chen, L. X., Wu, S., Donigan, A. M., Borghaei, R. C., and Soprano, K. J. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition. Oncogene, 12: 577-584, 1996.
27. Jonat, C., Rahmsdorf, H. J., Park, K-K., Cato, A. C. B., Gebel, S., Ponta, H., and Herrlich, P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell, 62: 1189-1204. 1990.
28. Schüle, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone. L. J., Bolado, J., Verma, I. M., and Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA, 88: 6092-6096, 1991.
29. Chen, J-Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J., 14: 1187-1197, 1995.
30. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-110, 1994.
31. Scheck, R., Rieber, P., and Baeuerle, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κ B transcription factor and HIV-1. EMBO J., 10: 2247-2258, 1991.
32. Meyer, M., Schreck, R., and Baeuerle, P. A. Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κ-B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J., 12: 2005-2015, 1993.
33. Schenk, H., Klein, M., Erdbrugger, W., Droge, W., and Schulze-Osthoff, K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κ B and AP-1. Proc. Natl. Acad. Sci. USA, 91: 1672-1676, 1994.
34. Schreck, R., Meier, B., Maennel, D. N., Droge, W., and Baeuerle, P. A. Dithiocar-bamates as potent inhibitors of nuclear factor κ-B activation in intact cells. J. Exp. Med., 175: 1181-1194, 1992.
35. Ziegle-Heitbrock, H. W. L., Sternsdork, T., Liese, J., Belohracdsky, B., Weber, C., Wedel, A., Schreck, R., Baeuerle, P., and Stroebel, M. Pyrrolidine dithiocarbamate inhibits NF-kappa-B mobilization and TNF production in human monocytes. J. Immunol., 151: 6986-6993, 1993.
36. Kawai, M., Nishikomori, R., Jung, E. Y., Tai, G., Yamanaka, C., Mayumi, M., and Heike, T. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J. Immunol., 154: 2333-2341, 1995.
37. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J., and Herrlich, P. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol., 7: 2256-2266, 1987.
38. Schorpp, M., Mattei, M-G., Herr, I., Gack, S., Schaper, J., and Angel, P. Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem. J., 308: 211-217, 1995.
39. Dong, Z., Lavrovsky, V., and Colburn, N. C. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis (Lond.), 16: 747-756, 1995.
40. Gorman, C. M, Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.
41. Ye, J., Young, H. A., Ortaldo, J. R., and Ghosh, P. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter. Nucleic Acids Res., 22: 5672-5678, 1994.
42. Benedetti, F. D., Colburn, N. H., Oppenheim, J. J., and Faltynek, C. R. Tumor necrosis factor induces anchorage independent growth of two murine non-transformed cell lines. Mol. Cell. Biol. Cytokines, 5: 275-280, 1990.
43. Colburn, N. H. Genes and Signal Transduction in Multistage Carcinogenesis, New York: Marcel Dekker, 1989.
44. Yang-Yen, H-F., Zhang, X-K., Graupner, G., Tzukerman, M., Sakamoto, B., Karin, M., and Pfahl, M. Antagonism between retinoic acid reporters and AP-1: implication for tumor promotion and inflammation. New Biol., 3: 1216-1219, 1991.
45. Thanos, D., and Maniatis, T. NF-κB. A lesson in family values. Cell, 80: 529-532, 1995.
46. Beato, M., Herrlich, P., and Schütz, G. Steroid hormone receptors: many actors in search of a plot. Cell, 83: 851-857, 1995.
47. Yang-Yen, H-F., Chambard, J-C., Sun, Y-L., Smeal, T., Schmidt, T. J., Drouin, J., and Karin, M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell, 62: 1205-1215, 1990.
48. Kwok, R. P., Lundblad, J. R., Chrivia, J. C., Richard, J. P., Bachinger, H. P., Brennan, R. G., Robert, S. G., Green, M. R., and Goodman, R. H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (Lond.), 370: 223-226, 1992.
49. Aria, J., Alberts, A. S., Brindle, P., Claret, F. X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature (Lond.), 370: 226-229, 1994.
50. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S-C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.